CanniMed Therapeutics Inc.

CMED on TSXToday's ChangeVol. / Avg.52 Week Range (Low/Hi)Market Cap
11.33CAN -0.07/-0.61%6,453/75,08410.28 / 13.35243.80M
Powered by: Google Finance

Contact Information

CanniMed Therapeutics Inc.

Headquarters:
1 Plant Technology Road, Box 19A, RR#5
Saskatoon, Saskatchewan
S7K 3J8, Canada
Tel: 1-306-978-6848
Fax: 1‑844‑231‑8929
Email: Send a message
Website: Visit website
For more information...
Lead: Barry Mire

The Company is a Canadian-based, international plant biopharmaceutical company and leader in the Canadian medical cannabis industry, with 15 years’ of pharmaceutical cannabis cultivation experience, state-of-the-art, a GMP-compliant production process, including 281 points of quality control and world class research and development platforms with a wide range of pharmaceutical-grade cannabis products.

The Company also has an active plant biotechnology research and product development program focused on the production of plant-based materials for pharmaceutical, agricultural and environmental applications.

Donald Ching - Chairman and Director
Brent Zettl - President, Chief Executive Officer and Director
John L. Knowles - Chief Financial Officer and Director
Gulwant Bajwa - Vice President, Business Development and Regulatory Affairs
Larry Holbrook - Chief Research Officer
 

Donald Ching - Chairman and Director
Brent Zettl - President, Chief Executive Officer and Director
John L. Knowles - Chief Financial Officer and Director
Doug Banzet - Director
Rob Duguid - Director
Marianne Greer - Director
Richard Hoyt - Director
Dwayne L. Lashyn - Director
Dr. Bruce F. Mackler - Director
Dr. Brandon J. Price - Director

 

Stock Information

CMED on TSX
0.00CAN
Today's Change
0.00/0.00%
Volume
0

Company Overview

The Company is a Canadian-based, international plant biopharmaceutical company and leader in the Canadian medical cannabis industry, with 15 years’ of pharmaceutical cannabis cultivation experience, state-of-the-art, a GMP-compliant production process, including 281 points of quality control and world class research and development platforms with a wide range of pharmaceutical-grade cannabis products.

The Company also has an active plant biotechnology research and product development program focused on the production of plant-based materials for pharmaceutical, agricultural and environmental applications.

Management

Donald Ching - Chairman and Director
Brent Zettl - President, Chief Executive Officer and Director
John L. Knowles - Chief Financial Officer and Director
Gulwant Bajwa - Vice President, Business Development and Regulatory Affairs
Larry Holbrook - Chief Research Officer
 

Board of Directors

Donald Ching - Chairman and Director
Brent Zettl - President, Chief Executive Officer and Director
John L. Knowles - Chief Financial Officer and Director
Doug Banzet - Director
Rob Duguid - Director
Marianne Greer - Director
Richard Hoyt - Director
Dwayne L. Lashyn - Director
Dr. Bruce F. Mackler - Director
Dr. Brandon J. Price - Director

 

Contact Information

Headquarters:
1 Plant Technology Road, Box 19A, RR#5
Saskatoon, Saskatchewan
S7K 3J8, Canada
Telephone: 1-306-978-6848
Fax: 1‑844‑231‑8929
Email: Send a message
Website: Visit website